STAAR Surgical Company (STAA) climbed 7.86%, rising $1.85 to $25.39, after the company issued an updated full-year outlook driven by better-than-expected sales of its implantable lenses.
The company cited strong demand in its refractive lens business as a key factor behind the revised guidance.
Investors reacted positively to the revised guidance, sending trading volume well above average. The stock's 52-week range is approximately $14.20 - $28.50.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.